Finance

These popular stocks could deliver big wins for your portfolio if you hold them for the long term.

Even if you aren’t crazy about the company’s COVID-19 vaccine, this is still a growth investment worth considering for your portfolio.

A promising acquisition serves as a reminder of this fintech’s potential.

The company continues to impress with its latest profit numbers.

A bigger monthly benefit could mean a more comfortable retirement for you.

Ecolab is poised to restart revenue growth and expand its market share in a post-pandemic world.

Zero hype. Just results.

These three stocks could see huge tailwinds from the launch of 5G technology.

Damien Peters, founder of Wealth Noir, on how to get started investing today despite the obstacles in your way.

Don’t spend too much time looking at a stock’s price — consider more important things in your analysis.

You could receive more money than you think.

Are you on track with retirement savings? This is what baby boomers have socked away.

One analyst initiated coverage on the stock with an unhesitant buy recommendation.

It might be that Biogen, too, is abandoning the theory that amyloid plaque is the cause of the disease.

The company’s second-quarter net loss was a bit deeper than analysts expected.

Analysts cooled on the company’s prospects following its latest earnings report.

Carnival’s guests are mostly coronavirus-free — but what about the crew?

AGRO earnings call for the period ending June 30, 2021.

The biotech stock has lost half of its value over the past week.

The mortgage titan expects business to remain brisk in the second half of 2021.